Eteri

2-(3,4,5-Trimethoxyphenyl)ethylamine (TMPEA), also known as 3,4,5-trimethoxyamphetamine or 3,4,5-trimethoxyphenethylamine is a psychoactive agent that is structurally related to amphetamine and mescaline. It is a precursor to TMA which is an hallucinogenic drug. TMPEA has been shown to have dose-dependent effects on locomotor activity in mice and rats. In addition, it has been found to bind with high affinity to 5HT2A receptors in the rat brain. This compound can be prepared by reacting trifluoroacetic acid with 2-(3,4,5-trimethoxyphenyl)ethanamine. The sample preparation of this compound may be performed using human serum or lophophora plants.

(3,3-Diethoxyprop-1-en-1-yl)benzene is a compound that has been synthesized in the laboratory. It is a cinnamic acid derivative with a benzene ring. (3,3-Diethoxyprop-1-en-1-yl)benzene has shown to be an inhibitor of serotonin reuptake and damaging to mammalian cells. It also inhibits the synthesis of serotonin by blocking the binding site for serotonin on the cell membrane. The compound may have potential as a treatment for depression and anxiety disorders due to its effects on serotonin levels and its ability to inhibit monoamine oxidase B.

3-(4-Fluorobenzoyl)-6-Methoxy-2-Methyl-1H-Indole-1-Acetic Acid is a prodrug that is metabolized to 6-fluoro-3,4 dioxo tamoxifen in the liver. It has been shown to have anticholinergic, cytosolic calcium and c1-4 alkyl properties. 3-(4-Fluorobenzoyl)-6-Methoxy-2-Methylindole Acetic Acid also has a basic group, cyclopentane ring, and pyridine ring.

3-Methoxybenzhydrazide is a molecule that has been studied for its biological properties. It has the ability to inhibit tyrosinase, an enzyme involved in melanin production, and is a potent inhibitor of bacterial growth. 3-Methoxybenzhydrazide also has the property of fluorescence, which can be used to detect its presence in cells. The stability of this molecule has been studied by x-ray crystallography and it is found to have high structural stability. 3-Methoxybenzhydrazide has been shown to be potentially useful for cancer research due to its ability to suppress tumor growth in mice.

1-(3,4-Dimethoxyphenyl)-2-nitroethene is a trifluoroacetic acid derivative that can be synthesized using the reaction of 1-(3,4-dimethoxyphenyl)ethanone and 2-nitroethanol. It is an unsymmetrical molecule with two possible structures. The first structure is postulated to be the energetically favored conformation, while the second structure is postulated to be the result of elimination of HCl during synthesis. This compound has shown potential as a prodrug for amine-containing drugs such as resveratrol or hydrazines.